Pfizer
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.
RELATED ARTICLES
Researcher Profile: Dr. Yasmeen Agosti
At Pfizer, Yasmeen works to develop maternal vaccines that have the potential to help prevent diseases from affecting at-risk infants.
Researcher Profile: Dr. Marie-Claire Peakman
Dr. Marie-Claire Peakman always knew she wanted to make a difference in the world.
Why innovation is vital: My battle with C. difficile
Simon Jenkins, who suffered from C. diff, shares his story and hope for future treatments.
Researcher Profile: Michael Pride
To demonstrate the incredible work pursued by America's biopharmaceutical researchers, we're sharing the story of Dr. Michael Pride, a Pfizer scientist who is working on preventative vaccines for the bacterium Clostridium difficile (C. difficile).
I Just Want to Show Other Patients that Anything is Possible
Today is World Duchenne Awareness Day, which aims to raise awareness for people living with Duchenne muscular dystrophy (DMD).
Researcher Profile: Jane Owens
Dr. Owens is a senior director who manages rare muscle disease research projects in Pfizer's Rare Disease Research Unit.
Vaccines: Cutting Health Care Costs While Saving Countless Lives
In the United States, 16 diseases are now preventable as a result of childhood vaccines, resulting in an estimated $1.4 trillion in societal costs saved.
Lung Cancer Gets Personal
Lung cancer counts for 25% of all cancer deaths in the U.S. That's why every day, researchers search relentlessly to unearth more innovative breakthroughs. Thanks to their dedication, there are now 240 immuno-oncology treatments in development to give hope and a future for patients with cancer.
Researcher Profile: Kelly Knee
As a principal scientist working on sickle cell disease in the Rare Disease Research Unit (RDRU) at Pfizer, Kelly Knee is a jack of all trades.
Recognizing Diversity in Clinical Trials
Every time you take a medicine – even if it's just for a headache – you are benefitting from the results of a clinical trial.
Building "Smart Bombs" to Attack Cancer
Biopharmaceutical researchers are investigating a new type of therapy that has the potential to attack cancer cells while leaving healthier cells unharmed.
POPULAR ARTICLES
HIV/AIDS: From An Acute Fatal Disease to A Chronic, Manageable Condition
<p>The evolution of HIV/AIDS treatment is nothing short of remarkable. In the 1980s, HIV/AIDS was an acute fatal disease. Today it is a chronic, manageable condition thanks to the commitment of biopharmaceutical researchers, health care workers and advocates.</p>
READ MORE
Combatting Sickle Cell Disease with Cell & Gene Therapy
<p><span><span><span><a><span lang="EN"><span>America's biopharmaceutical companies are researching and developing new treatments to alleviate the tremendous burden of this devastating and painful disease and to improve the quality of life for sickle cell patients.</span></span></a></span></span></span></p>
READ MORE
Why Has Research into Alzheimer's Disease Been So Hard?
<p>Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?</p>
READ MORE
5 Recent Developments Advancing Vaccines
As communities continue to grapple with the impact of COVID-19, vaccines have once again come to the forefront as a critical health care tool.
READ MORE
The Innovation Ecosystem Fuels Breakthroughs
Biopharmaceutical research companies are uniquely positioned to take the necessary risks to further advance research into safe and effective treatments for patients.
READ MORE
Understanding mRNA Vaccines
Scientists are breaking barriers with mRNA technology, one of the approaches used to develop COVID-19 vaccines.
READ MORE
Protecting Alzheimer's Research
15 million people will live with Alzheimer's by 2060. We're working to change that.
READ MORE